Drug Makers: Most People Don’t Pay Retail

Executives are pushing back against the recent outcry over high drug costs, saying media outlets are focusing on the list prices rather than the discounted ones they say consumers are actually paying. In other pharmaceutical news, Merck settles a class action lawsuit over a painkiller it pulled from the market, and the costs of targeted cancer drugs is growing.